Literature DB >> 25806337

Reflections on immune checkpoint inhibition in non-small cell lung cancer.

Konstantinos Leventakos1, Aaron S Mansfield1.   

Abstract

Entities:  

Year:  2014        PMID： 25806337      PMCID： PMC4367678          DOI： 10.3978/j.issn.2218-6751.2014.09.09

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  5 in total

1.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.

Authors:  H Dong; G Zhu; K Tamada; L Chen
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

Review 2.  Incorporating immune-checkpoint inhibitors into systemic therapy of NSCLC.

Authors:  Stéphane Champiat; Ecaterina Ileana; Giuseppe Giaccone; Benjamin Besse; Giannis Mountzios; Alexander Eggermont; Jean-Charles Soria
Journal:  J Thorac Oncol       Date:  2014-02       Impact factor: 15.609

3.  Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

Authors:  Julie R Brahmer; Charles G Drake; Ira Wollner; John D Powderly; Joel Picus; William H Sharfman; Elizabeth Stankevich; Alice Pons; Theresa M Salay; Tracee L McMiller; Marta M Gilson; Changyu Wang; Mark Selby; Janis M Taube; Robert Anders; Lieping Chen; Alan J Korman; Drew M Pardoll; Israel Lowy; Suzanne L Topalian
Journal:  J Clin Oncol       Date:  2010-06-01       Impact factor: 44.544

4.  Programmed death ligand-1 expression in non-small cell lung cancer.

Authors:  Vamsidhar Velcheti; Kurt A Schalper; Daniel E Carvajal; Valsamo K Anagnostou; Konstantinos N Syrigos; Mario Sznol; Roy S Herbst; Scott N Gettinger; Lieping Chen; David L Rimm
Journal:  Lab Invest       Date:  2013-11-11       Impact factor: 5.662

5.  Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Authors:  Haidong Dong; Scott E Strome; Diva R Salomao; Hideto Tamura; Fumiya Hirano; Dallas B Flies; Patrick C Roche; Jun Lu; Gefeng Zhu; Koji Tamada; Vanda A Lennon; Esteban Celis; Lieping Chen
Journal:  Nat Med       Date:  2002-06-24       Impact factor: 53.440
  5 in total
  5 in total

1.  Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma.

Authors:  Aaron S Mansfield; Tobias Peikert; James B Smadbeck; Julia B M Udell; Enrique Garcia-Rivera; Laura Elsbernd; Courtney L Erskine; Virginia P Van Keulen; Farhad Kosari; Stephen J Murphy; Hongzheng Ren; Vishnu V Serla; Janet L Schaefer Klein; Giannoula Karagouga; Faye R Harris; Carlos Sosa; Sarah H Johnson; Wendy Nevala; Svetomir N Markovic; Aaron O Bungum; Eric S Edell; Haidong Dong; John C Cheville; Marie Christine Aubry; Jin Jen; George Vasmatzis
Journal:  J Thorac Oncol       Date:  2018-10-10       Impact factor: 15.609

2.  Heterogeneity of Programmed Cell Death Ligand 1 Expression in Multifocal Lung Cancer.

Authors:  Aaron S Mansfield; Stephen J Murphy; Tobias Peikert; Eunhee S Yi; George Vasmatzis; Dennis A Wigle; Marie Christine Aubry
Journal:  Clin Cancer Res       Date:  2015-12-14       Impact factor: 12.531

3.  Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis.

Authors:  Renata Duchnowska; Rafał Pęksa; Barbara Radecka; Tomasz Mandat; Tomasz Trojanowski; Bożena Jarosz; Bogumiła Czartoryska-Arłukowicz; Wojciech P Olszewski; Waldemar Och; Ewa Kalinka-Warzocha; Wojciech Kozłowski; Anna Kowalczyk; Sherene Loi; Wojciech Biernat; Jacek Jassem
Journal:  Breast Cancer Res       Date:  2016-04-27       Impact factor: 6.466

4.  Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer.

Authors:  A S Mansfield; M C Aubry; J C Moser; S M Harrington; R S Dronca; S S Park; H Dong
Journal:  Ann Oncol       Date:  2016-08-08       Impact factor: 32.976

5.  Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.

Authors:  Jianqin Lu; Xiangsheng Liu; Yu-Pei Liao; Xiang Wang; Ayman Ahmed; Wen Jiang; Ying Ji; Huan Meng; Andre E Nel
Journal:  ACS Nano       Date:  2018-10-16       Impact factor: 15.881
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.